Khurana V - Search Results

1

Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors.

Khurana V, Minocha M, Pal D, Mitra AK. Khurana V, et al. Drug Metabol Drug Interact. 2014;29(3):179-90. doi: 10.1515/dmdi-2013-0062. Drug Metabol Drug Interact. 2014. PMID: 24643910 Free PMC article.

2

Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.

Khurana V, Minocha M, Pal D, Mitra AK. Khurana V, et al. Drug Metabol Drug Interact. 2014;29(4):249-59. doi: 10.1515/dmdi-2014-0014. Drug Metabol Drug Interact. 2014. PMID: 24807167 Free PMC article.

3

Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib.

Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Minocha M, et al. Among authors: khurana v. Int J Pharm. 2012 Oct 15;436(1-2):127-34. doi: 10.1016/j.ijpharm.2012.05.038. Epub 2012 Jun 9. Int J Pharm. 2012. PMID: 22688250 Free PMC article.

4

Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.

Kwatra D, Vadlapudi AD, Vadlapatla RK, Khurana V, Pal D, Mitra AK. Kwatra D, et al. Among authors: khurana v. Drug Metabol Drug Interact. 2014;29(2):101-10. doi: 10.1515/dmdi-2013-0056. Drug Metabol Drug Interact. 2014. PMID: 24399676 Free PMC article.

5

Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.

Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Minocha M, et al. Among authors: khurana v. Int J Pharm. 2012 Sep 15;434(1-2):306-14. doi: 10.1016/j.ijpharm.2012.05.028. Epub 2012 May 23. Int J Pharm. 2012. PMID: 22633931 Free PMC article.

6

Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.

Luo S, Wang Z, Patel M, Khurana V, Zhu X, Pal D, Mitra AK. Luo S, et al. Among authors: khurana v. Int J Pharm. 2011 Jul 29;414(1-2):77-85. doi: 10.1016/j.ijpharm.2011.05.001. Epub 2011 May 7. Int J Pharm. 2011. PMID: 21571053 Free PMC article.

7

Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).

Minocha M, Khurana V, Mitra AK. Minocha M, et al. Among authors: khurana v. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jul 15;901:85-92. doi: 10.1016/j.jchromb.2012.06.004. Epub 2012 Jun 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2012. PMID: 22749591 Free PMC article.

8

Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.

Khurana V, Kwatra D, Pal D, Mitra AK. Khurana V, et al. Int J Pharm. 2014 Oct 20;474(1-2):14-24. doi: 10.1016/j.ijpharm.2014.07.056. Epub 2014 Aug 4. Int J Pharm. 2014. PMID: 25102111 Free PMC article.

9

Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells.

Khurana V, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Khurana V, et al. Curr Eye Res. 2015 May;40(5):457-69. doi: 10.3109/02713683.2014.935443. Epub 2014 Jul 11. Curr Eye Res. 2015. PMID: 25014399 Free PMC article.

10

Transporter effects on cell permeability in drug delivery.

Mandal A, Agrahari V, Khurana V, Pal D, Mitra AK. Mandal A, et al. Among authors: khurana v. Expert Opin Drug Deliv. 2017 Mar;14(3):385-401. doi: 10.1080/17425247.2016.1214565. Epub 2016 Aug 5. Expert Opin Drug Deliv. 2017. PMID: 27449574 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters